Evidence map›Paper›PMID 38433180›Full record

ArticleBreast cancer (Tokyo, Japan)2024

Reply to comment on 'An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers' by Fukui et al.

Reiko Fukui, Takahiro Watanabe, Koji Morimoto, Yukie Fujimoto, Masayuki Nagahashi, Eri Ishikawa, Seiichi Hirota, Yasuo Miyoshi

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Breast cancer (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Reiko FukuiDepartment of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Mukogawa-cho 1-1, Nishinomiya City, Hyogo, 663-8501, Japan.
Takahiro WatanabeDepartment of Clinical Pathology, Chibune General Hospital, Osaka, Japan.
Koji MorimotoDepartment of Nutrition, College of Nutrition, Koshien University, Takarazuka, Hyogo, Japan.
Yukie FujimotoDepartment of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Mukogawa-cho 1-1, Nishinomiya City, Hyogo, 663-8501, Japan.
Masayuki NagahashiDepartment of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Mukogawa-cho 1-1, Nishinomiya City, Hyogo, 663-8501, Japan.
Eri IshikawaDepartment of Surgical Pathology, School of Medicine, Hyogo Medical University, Nishinomiya City, Hyogo, Japan.
Seiichi HirotaDepartment of Surgical Pathology, School of Medicine, Hyogo Medical University, Nishinomiya City, Hyogo, Japan.
Yasuo MiyoshiDepartment of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Mukogawa-cho 1-1, Nishinomiya City, Hyogo, 663-8501, Japan. ymiyoshi@hyo-med.ac.jp.ORCID http://orcid.org/0000-0001-8535-4008
Chibune General Hospital · JPHyogo Medical University · JPKoshien University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Agents, HormonalBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesLymphocytes, Tumor-InfiltratingNeoadjuvant TherapyReceptors, EstrogenFemaleHumansAntineoplastic Agents, HormonalERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesReceptors, Estrogen

Identifiers

PMID38433180
OpenAlexW4392613501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.